Adocia Stock Fundamentals

ADOC Stock  EUR 4.41  0.06  1.34%   
Adocia fundamentals help investors to digest information that contributes to Adocia's financial success or failures. It also enables traders to predict the movement of Adocia Stock. The fundamental analysis module provides a way to measure Adocia's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Adocia stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Adocia Company Current Valuation Analysis

Adocia's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Adocia Current Valuation

    
  33.73 M  
Most of Adocia's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Adocia is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Adocia has a Current Valuation of 33.73 M. This is 99.77% lower than that of the Biotechnology sector and 99.27% lower than that of the Health Care industry. The current valuation for all France stocks is 99.8% higher than that of the company.

Adocia Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Adocia's current stock value. Our valuation model uses many indicators to compare Adocia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Adocia competition to find correlations between indicators driving Adocia's intrinsic value. More Info.
Adocia is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Adocia by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Adocia's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Adocia Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Adocia's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Adocia could also be used in its relative valuation, which is a method of valuing Adocia by comparing valuation metrics of similar companies.
Adocia is currently under evaluation in current valuation category among its peers.

Adocia Fundamentals

About Adocia Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Adocia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adocia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adocia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Adocia SA was founded in 2005 and is headquartered in Lyon, France. ADOCIA operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 116 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Adocia Stock

Adocia financial ratios help investors to determine whether Adocia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Adocia with respect to the benefits of owning Adocia security.